Novogen has novel operations in over-the-counter pharmaceutical sales and prescription drug development. The company's consumer division develops and markets OTC products for women's and men's health. Commercialized products include Promensil for female menopause symptoms, Vinilac supplements for pregnant and nursing women, and Trinoven, a supplement that promotes male prostate health. Novogen's Australian prescription drug division and its US subsidiary Marshall Edwards conduct research and development efforts in areas including oncology, cardiovascular health, and gastrointestinal and inflammatory conditions.